BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Capsida Biotherapeutics

Capsida Biotherapeutics logo

Clinical Trials



Capsida is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders. It features a proprietary adeno-associated virus (AAV) engineering platform that generates capsids optimized to target specific tissues and cells in the diseased organ.

adeno-associated virus genetic disorders gene therapy

Posts Mentioning This Company

Companies Driving Innovation To Fight Alzheimer’s Disease

The overall technological progress in medicine and the overall increase in the quality and safety of life, compared to even a century ago, led to a substantial growth of the population, and longer life expectancy for humans -- more and more people live up to their  60s, 70s, 80s and …